almost every hospital worldwide, in clinics and in the home. For over 85 years, we have pioneered significant medical innovations... with and providing reasonable accommodations to individuals with disabilities globally. If, because of a medical condition or disability...
, anticipating changes in medical science and technology. Working at Abbott At Abbott, you can do work that matters, grow..., and scientists. The Opportunity We’re empowering smarter medical and economic decision making to help transform the way people...
MEDICAL EDUCATOR CDMX AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses... professionals. Provides scientific, technical and pharmaco-economic information to customers. May also deliver medical education...
almost every hospital worldwide, in clinics and in the home. For over 85 years, we have pioneered significant medical innovations... to individuals with disabilities globally. If, because of a medical condition or disability, you need a reasonable accommodation...
Watch the reaction from England fans and the BBC presenting team as Gareth Southgate’s side beat Switzerland on penalties in the quarter-finals of Euro 2024. Continue Reading »
Latest Market News Today Live Updates: Follow Mint's market blog for real-time updates on your favourite companies. This blog keeps you informed on all things Dalal Street and global markets. Continue Reading »
FPIs invested ₹7,962 crore worth of Indian equities and the net investment stood at ₹14,128 crore as of July 5, taking into account debt, hybrid, debt-VRR, and equities Continue Reading »
Vaishali Parekh, Vice President - Technical Research of Prabhudas Lilladher Pvt. Ltd is bullish on Apollo Hospitals, TVS Motor Company, and CONCOR and sees an upside potential of 14 per cent. Continue Reading »
Dividend Stocks: Several companies including AU Small Finance Bank, JK Cement, Axis Bank, among others are trading ex-dividend in the coming week. Continue Reading »
New Street Research's Pierre Ferragu downgraded Nvidia's stock to a 'neutral' rating from a ‘buy’ rating stating valuation concerns. The chipmaker's shares surged 154 per cent this year over a gain of 240 per cent in the previous year 2023. Continue Reading »